Header cover image

Brazilian Pharmaceuticals & Biotech High And Sustainable

Results

1

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

1 companies

Hypera

Market Cap: R$14.6b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$20.73

7D

-5.1%

1Y

-10.8%